Evidence map›Paper›PMID 28364323›Full record

ArticleClinical and experimental nephrology2017

Circulating and renal expression of HLA-G prevented chronic renal allograft dysfunction in Japanese recipients.

Yuki Okushi, Kazuaki Okino, Kiyotaka Mukai, Yuki Matsui, Norifumi Hayashi, Keiji Fujimoto, Hiroki Adachi, Hideki Yamaya, Hitoshi Yokoyama

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical and experimental nephrology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yuki OkushiDepartment of Nephrology, Kanazawa Medical University School of Medicine, Daigaku, Uchinada, Ishikawa, 920-0293, Japan. okushi@kanazawa-med.ac.jp.
Kazuaki OkinoDepartment of Nephrology, Kanazawa Medical University School of Medicine, Daigaku, Uchinada, Ishikawa, 920-0293, Japan.
Kiyotaka MukaiDepartment of Nephrology, Kanazawa Medical University School of Medicine, Daigaku, Uchinada, Ishikawa, 920-0293, Japan.
Yuki MatsuiDepartment of Nephrology, Kanazawa Medical University School of Medicine, Daigaku, Uchinada, Ishikawa, 920-0293, Japan.
Norifumi HayashiDepartment of Nephrology, Kanazawa Medical University School of Medicine, Daigaku, Uchinada, Ishikawa, 920-0293, Japan.
Keiji FujimotoDepartment of Nephrology, Kanazawa Medical University School of Medicine, Daigaku, Uchinada, Ishikawa, 920-0293, Japan.
Hiroki AdachiDepartment of Nephrology, Kanazawa Medical University School of Medicine, Daigaku, Uchinada, Ishikawa, 920-0293, Japan.
Hideki YamayaDepartment of Nephrology, Kanazawa Medical University School of Medicine, Daigaku, Uchinada, Ishikawa, 920-0293, Japan.
Hitoshi YokoyamaDepartment of Nephrology, Kanazawa Medical University School of Medicine, Daigaku, Uchinada, Ishikawa, 920-0293, Japan. h-yoko@kanazawa-med.ac.jp.ORCID http://orcid.org/0000-0002-7753-1366
Kanazawa Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough the risk of acute rejection has been studied in renal transplanted patients, there is little data about the long-term renal survival effects of non-classical human leukocyte antigen class I (HLA-G) in Japanese patients.

methodWe investigated the changes in the estimated glomerular filtration rate (eGFR) for Japanese, and factors affecting the eGFR in 141 adult Japanese subjects whose allografts had survived for at least 1 year. Clinical background data, gender, HLA matching status, the total ischemic time, ABO incompatibility, immunosuppressive therapy, and the serum soluble(s) HLA-G5 level were examined. In addition, renal biopsy specimens from 32 cases, which were obtained before, or 2-4 weeks or one year after the transplant were also evaluated for HLA-G1/5 expression using monoclonal anti-HLA-G antibodies (clone 87G or 4H84).

resultsThe rates of change per year in the median eGFR (ΔeGFR) and sHLA-G5 were -1.5 ml/min/1.73 m

Indexed as

Kidney TransplantationAdultAllograftsBiomarkersChi-Square DistributionChronic DiseaseFemaleGlomerular Filtration RateGraft RejectionGraft SurvivalHistocompatibilityHLA-G AntigensHumansImmunosuppressive AgentsJapanKidneyBiomarkersHLA-G AntigensImmunosuppressive AgentsEstimated glomerular filtration rate (eGFR)Non-classical human leukocyte antigen class I (HLA-G)Renal transplantationRenal tubular epithelial cells

Identifiers

PMID28364323
OpenAlexW2604101207

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.